• Newly revitalized and expanding Initiatives to Move Discoveries to Drugs and Diagnostics
• Graduate student partnering and development; Fall Fest, travel awards and presentations
• Established collaborations of unconventional combinations, with more in progress
• Winning concepts, new grants, patents and licenses
• IMD3 Symposium on contemporary topics
• Modern instrumentation for characterization and analysis
• Industrial collaborations and  internships
• Combinatorial chemistry; high throughput screening
• Molecular modeling and drug design
• Database development and mining
• ab initio molecular structure for defined functions
• Protein and steroid hormone mimics by design
• Cell surface characteristics, trafficking and signaling
• Sensitive receptor assays for assessing compound activities
• Unique IMD3 collection of compounds with diverse structures
• Expertise with peptides, carbohydrates, nucleic acids, lipids, and natural products
• University fellowships and summer scholars program for multidisciplinary training
• Genomics, proteomics and metabolomics for assessing disease status and identifying molecular targets

Current initiatives include establishing benchmarks for funding and publications, attracting additional industrial support, increasing patents and licensing opportunities, adding another endowed chair, designing a facility for a core synthesis and chemical collection storage and a chemoinformatics laboratory, and submitting a joint research proposal or training grant to a national funding agency.